Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions.
about
Stable isotope-resolved metabolomics and applications for drug developmentRegulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cellsImaging in breast cancer: Magnetic resonance spectroscopyIn vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian CancerMagnetic resonance imaging in breast cancer: A literature review and future perspectivesClinical Breast MR Using MRS or DWI: Who Is the Winner?Improved hardware for higher spatial resolution strain-encoded (SENC) breast MRI for strain measurements.Tumour T1 changes in vivo are highly predictive of response to chemotherapy and reflect the number of viable tumour cells--a preclinical MR study in mice.Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study.Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications.Decreases in free cholesterol and fatty acid unsaturation in renal cell carcinoma demonstrated by breath-hold magnetic resonance spectroscopy.Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo.Non-invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism.Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy.Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T.Proton and phosphorus magnetic resonance spectroscopy of the healthy human breast at 7 T.Effect of Gd-DTPA-BMA on choline signals of HT29 tumors detected by in vivo 1H MRS.Feasibility of single-voxel MRS measurement of apparent diffusion coefficient of water in breast tumors.A high spatial resolution in vivo 1H magnetic resonance spectroscopic imaging technique for the human breast at 3 T.Characterization of metabolic differences between benign and malignant tumors: high-spectral-resolution diffuse optical spectroscopy.Biochemical characterization of breast tumors by in vivo and in vitro magnetic resonance spectroscopy (MRS)Organic cation uptake is enhanced in bcrp1-transfected MDCKII cellsIs there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA.Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models.Breast Tissue Metabolism by Magnetic Resonance Spectroscopy.Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS study.Magnetic resonance in the detection of breast cancers of different histological types.A hyperpolarized choline molecular probe for monitoring acetylcholine synthesis.In vivo 1H MRS in the assessment of the therapeutic response of breast cancer patientsGlycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancerAn implantable RF solenoid for magnetic resonance microscopy and microspectroscopy.Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapyDirect inhibition of choline kinase by a near-infrared fluorescent carbocyanineClinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS.Noninvasive imaging identifies new roles for cyclooxygenase-2 in choline and lipid metabolism of human breast cancer cellsCholine metabolism in malignant transformation.MR imaging of the breast: indications, established technique, and new directions.The role of magnetic resonance imaging in diagnosis and management of breast cancer.Magnetic resonance in surgical oncology: II - literature review.
P2860
Q24629149-EB43B32C-1972-40F7-A978-95E6D5EE2E9AQ24646815-2EE441EA-A16F-4315-9EA2-29568175EF55Q24810795-DC35D2D3-DB0A-448F-8ABD-8714C2792714Q26742109-08F35DEF-87D6-4FED-B608-31E9899E2E7CQ26992206-5EA691DB-8772-4328-A42A-28B9D5DA5653Q28072837-68221182-F2B9-44FB-A62B-3286010E954AQ30428414-1A942B45-A0AA-4C65-80ED-305CFC744581Q30757279-9E5F0097-E430-41A9-92D7-70392834C45EQ30886805-31C5B832-4F94-4716-A485-C00F7602DF00Q30976981-510DE13D-0787-48C9-8FB8-D229FFB126D7Q30977535-00AFEC62-5369-43BA-81A5-6EB36180C00CQ31009512-32F7159B-F980-4123-B480-1AF21EEBDD09Q31027315-C138F83A-93D1-47E3-83C0-1D16E4A08E72Q31032006-08415338-66CD-48EA-9FF0-9AB68455FFDDQ31044575-06A98F52-DC50-4C01-8825-A8CED71300D3Q31151902-1519279E-4C00-4B8D-A81D-4913A4384392Q33381237-C26A743F-A830-4A93-93EC-BEB43A32BB78Q33411449-B4D1978E-28B7-4FD8-822E-E42E0750E341Q33517556-75756473-31D2-4734-974F-7861B1FA606BQ33520641-2F5FBAE4-2F59-44B1-B875-74947A1F9C3DQ33552272-CEFC1205-4C2C-49CD-97C5-1F977D40A4B3Q33624168-0F81CF64-37B5-4532-995B-6ECE669B502EQ33714951-E02F2BE6-15CB-446F-98DD-231B76ECAD2EQ33736511-70163082-E227-4DD9-89DD-4E8DC2AE2B27Q33844954-500399FD-5AF2-4E00-9858-31B97B094D4EQ33857530-63862680-82C5-4088-8048-3A0692D5AD33Q33873362-F3A9A9E1-6D56-4EE1-8707-5FEBBEEBF9EEQ33941482-D3EF53A7-E244-4C7F-96B6-0FEF20F6B006Q33972737-B07173A4-E810-4BB4-9D48-1DE7E218F225Q34020037-D3B9BE1C-F2EA-4B22-893D-FDE8E8C8473DQ34096215-3CB3E8B1-FD62-4AB5-A02D-31FC7505B894Q34140986-7CA74804-29DA-43B8-BE44-D8605A171889Q34348175-651A6D32-4E74-48B0-8E0A-84926F383C47Q34407085-6CF6C9B0-69AF-4767-926B-34DBF2B544FBQ34788629-97C158D4-37F5-4011-B60A-D518FE985304Q35112020-7B00A62D-F6A2-4036-BEA1-71EE9DD262FFQ35112040-E3431B7A-7627-453E-A36B-6B7A77A643FBQ35688693-3BE05287-BB5E-4807-A725-288965220E20Q35961071-2D47D703-C93E-4B98-8A56-28842EF6E40BQ36155915-07399415-332C-4162-A92B-273751C02D52
P2860
Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical utility of proton mag ...... characterizing breast lesions.
@ast
Clinical utility of proton mag ...... characterizing breast lesions.
@en
Clinical utility of proton mag ...... characterizing breast lesions.
@nl
type
label
Clinical utility of proton mag ...... characterizing breast lesions.
@ast
Clinical utility of proton mag ...... characterizing breast lesions.
@en
Clinical utility of proton mag ...... characterizing breast lesions.
@nl
prefLabel
Clinical utility of proton mag ...... characterizing breast lesions.
@ast
Clinical utility of proton mag ...... characterizing breast lesions.
@en
Clinical utility of proton mag ...... characterizing breast lesions.
@nl
P2093
P356
P1476
Clinical utility of proton mag ...... characterizing breast lesions.
@en
P2093
Philip T Lavin
Rachel Katz-Brull
Robert E Lenkinski
P304
P356
10.1093/JNCI/94.16.1197
P407
P577
2002-08-01T00:00:00Z